Role of macrophages in acute lung injury and chronic fibrosis induced by pulmonary toxicants

DL Laskin, R Malaviya, JD Laskin - Toxicological Sciences, 2019 - academic.oup.com
A diverse group of toxicants has been identified that cause injury to the lung including gases
(eg, ozone, chlorine), particulates/aerosols (eg, diesel exhaust, fly ash, other combustion …

Pathogenetic mechanisms in radiation fibrosis

J Yarnold, MCV Brotons - Radiotherapy and oncology, 2010 - Elsevier
Deregulation of normal regenerative responses to physical, chemical and biological toxins
in susceptible individuals leads to abnormal remodelling of extracellular matrix with …

The bleomycin model of pulmonary fibrosis

T Liu, FG De Los Santos, SH Phan - Fibrosis: Methods and Protocols, 2017 - Springer
Interstitial lung disease (ILD) comprises a large number of chronic lung disease
characterized by varying degrees of inflammation and fibrosis. Mostly they are idiopathic …

Interleukin-11 is a therapeutic target in idiopathic pulmonary fibrosis

B Ng, J Dong, G D'Agostino, S Viswanathan… - Science translational …, 2019 - science.org
Idiopathic pulmonary fibrosis (IPF) is a progressive fibrotic lung disease where invasive
pulmonary myofibroblasts secrete collagen and destroy lung integrity. Here, we show that …

[PDF][PDF] Ethnobotanical and ethnopharmacological studies of medicinal and aromatic plants used in the treatment of metabolic diseases in the Moroccan Rif

N Chaachouay, O Benkhnigue, M Fadli, H El Ibaoui… - Heliyon, 2019 - cell.com
Since early times, the people of Morocco use medicinal and aromatic plants as traditional
medicine to heal different human ailments. However, little studies have been made in the …

Antifibrotic activities of pirfenidone in animal models

CJ Schaefer, DW Ruhrmund, L Pan… - European …, 2011 - Eur Respiratory Soc
Pirfenidone is an orally active small molecule that has recently been evaluated in large
clinical trials for the treatment of idiopathic pulmonary fibrosis, a fatal disease in which the …

The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis?

A Moeller, K Ask, D Warburton, J Gauldie… - The international journal …, 2008 - Elsevier
Different animal models of pulmonary fibrosis have been developed to investigate potential
therapies for idiopathic pulmonary fibrosis (IPF). The most common is the bleomycin model …

Ethnobotany of medicinal plants among the communities of Alpine and Sub-alpine regions of Pakistan

S Kayani, M Ahmad, S Sultana, ZK Shinwari… - Journal of …, 2015 - Elsevier
Ethno-pharmacological relevance To best of our knowledge it is first quantitative ethno-
botanical study from Alpine and Sub-alpine, Western Himalaya of Pakistan. The study aims …

Antifibrotic action of pirfenidone and prednisolone: different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis

H Oku, T Shimizu, T Kawabata, M Nagira, I Hikita… - European journal of …, 2008 - Elsevier
Pirfenidone, a broad-spectrum antifibrotic agent, is known to have efficacy in certain fibrotic
disease models, and is under clinical trials in patients with idiopathic pulmonary fibrosis. We …

Modeling pulmonary fibrosis with bleomycin

MA Mouratis, V Aidinis - Current opinion in pulmonary medicine, 2011 - journals.lww.com
Despite its disadvantages, the bleomycin animal model remains the best available
experimental tool for studying disease pathogenesis and testing of novel pharmaceutical …